Business Context and Reporting Period
Company: MOOG INC.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2007 (Third Quarter of Fiscal Year 2007)
Business Overview: Moog is a global designer and manufacturer of high-performance precision motion and fluid controls for aerospace, defense, industrial, and medical markets. The company operates through five segments: Aircraft Controls, Space and Defense Controls, Industrial Controls, Components, and Medical Devices.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended June 30, 2007 |
Nine Months Ended June 30, 2007 |
Nine Months Ended July 1, 2006 |
|---|---|---|---|
| Net Sales | $403,789 | $1,144,684 | $965,743 |
| Gross Profit | $141,867 | $391,038 | $313,248 |
| Gross Margin | 35.1% | 34.2% | 32.4% |
| Net Earnings | $25,576 | $74,127 | $59,501 |
| Diluted EPS | $0.59 | $1.72 | $1.46 |
| Operating Cash Flow (9mo) | $7,298 | ||
| Total Assets | $1,900,897 | ||
| Total Debt (Long-term + Current) | $541,747 | ||
| Cash and Equivalents | $58,706 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 21% ($70 million) in the quarter and 19% ($179 million) year-to-date compared to the prior year. Growth was driven by all segments, including organic growth and contributions from acquisitions.
- Profitability: Net earnings rose 20% in the quarter and 25% year-to-date. Gross margins improved due to favorable product mix in Aircraft, Space/Defense, and Industrial segments.
- Acquisitions: Significant activity included the acquisition of ZEVEX International ($82 million) and Thermal Control Products ($6.9 million) in 2007, expanding the Medical Devices and Components segments.
- Expenses: Research and development (R&D) expenses increased significantly ($28.3 million in Q3 vs. $18.2 million prior year), primarily due to development work on the Boeing 787 Dreamliner. Selling, general, and administrative (SG&A) expenses as a percentage of sales increased slightly due to bid efforts and the higher cost structure of the new Medical Devices segment.
- Debt Levels: Total debt increased to fund acquisitions, capital expenditures, and working capital requirements. Interest expense rose accordingly.
Guidance, Outlook, and Risks
Management Outlook
- Fiscal 2007: Sales expected to increase 18% to approximately $1.54 billion. Operating margins expected to be 12.7% (up from 12.4% in 2006). Net earnings projected at $101 million with diluted EPS of $2.33.
- Fiscal 2008: Sales expected to increase 11-12% to approximately $1.72 billion. Operating margins projected at 13.1%. Net earnings expected between $115 million and $118 million.
- Segment Specifics: Aircraft Controls margins are expected to decline in 2007 due to high R&D investment but recover in 2008. Medical Devices margins are expected to improve significantly in 2008 following the integration of ZEVEX.
Risks and Contingencies
- Government Contracts: Dependence on government funding which may be reduced, delayed, or terminated.
- Customer Concentration: Significant reliance on major customers like Boeing and Lockheed Martin.
- Acquisition Integration: Risks associated with integrating acquired businesses and potential unknown liabilities.
- Market Risks: Foreign currency fluctuations, intense competition, and potential cost overruns on fixed-price contracts.
Investor Verification Checklist
- Boeing 787 Program: Verify the timeline and cost implications of the heavy R&D investment for the 787 Dreamliner and its impact on Aircraft Controls margins.
- Acquisition Integration: Assess the integration progress and financial performance of ZEVEX International and Thermal Control Products.
- Cash Flow Trends: Monitor the significant decrease in operating cash flow ($7.3 million vs. $30.2 million prior year) driven by working capital requirements (receivables and inventories).
- Debt Covenants: Confirm continued compliance with credit facility covenants, specifically the minimum net worth ($550 million) and leverage ratios, given increased debt levels.
- Contract Loss Reserves: Review the adequacy of contract loss reserves, noting the reduction in additions to reserves in 2007 compared to 2006.